High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma

Abstract Carbohydrate antigen 19‐9 (CA19‐9) fails to demonstrate the predictive value for early detection pancreatic ductal adenocarcinoma (PDAC). Glypican‐1 (GPC1+) exosomes may serve as a noninvasive diagnostic tool to detect early stages of PDAC. Therefore, it is necessary to explore the serum GP...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Cong‐ya Zhou, Yi‐ping Dong, Xiao Sun, Xin Sui, Hong Zhu, Ya‐qin Zhao, Yuan‐yuan Zhang, Clifford Mason, Qing Zhu, Su‐xia Han
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2018-11-01
Edice:	Cancer Medicine
Témata:	carbohydrate antigen 19‐9 diagnosis glypican‐1 pancreatic ductal adenocarcinoma prognosis serum biomarker
On-line přístup:	https://doi.org/10.1002/cam4.1833
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!